Cargando…
Harnessing the Activation of RIG-I Like Receptors to Inhibit Glioblastoma Tumorigenesis
Glioblastoma (GB) is an incurable form of brain malignancy in an adult with a median survival of less than 15 months. The current standard of care, which consists of surgical resection, radiotherapy, and chemotherapy with temozolomide, has been unsuccessful due to an extensive inter- and intra-tumor...
Autores principales: | Bufalieri, Francesca, Basili, Irene, Di Marcotullio, Lucia, Infante, Paola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295747/ https://www.ncbi.nlm.nih.gov/pubmed/34305530 http://dx.doi.org/10.3389/fnmol.2021.710171 |
Ejemplares similares
-
The RNA-Binding Ubiquitin Ligase MEX3A Affects Glioblastoma Tumorigenesis by Inducing Ubiquitylation and Degradation of RIG-I
por: Bufalieri, Francesca, et al.
Publicado: (2020) -
Proteolysis-Targeting Chimera (PROTAC): Is the Technology Looking at the Treatment of Brain Tumors?
por: Lospinoso Severini, Ludovica, et al.
Publicado: (2022) -
Targeting Hedgehog Signalling through the Ubiquitylation Process: The Multiple Roles of the HECT-E3 Ligase Itch
por: Infante, Paola, et al.
Publicado: (2019) -
DUBs Activating the Hedgehog Signaling Pathway: A Promising Therapeutic Target in Cancer
por: Bufalieri, Francesca, et al.
Publicado: (2020) -
A Smo/Gli Multitarget Hedgehog Pathway Inhibitor Impairs Tumor Growth
por: Lospinoso Severini, Ludovica, et al.
Publicado: (2019)